好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Late-onset Tremor and Ataxia in a Patient with a Family History of Fragile X: A Case of FXTAS Unveiled
Movement Disorders
P6 - Poster Session 6 (11:45 AM-12:45 PM)
5-018
N/A

Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is a late-onset neurodegenerative disorder caused by trinucleotide (CGG) expansions of 55-200 repeats in the Fragile X Mental Retardation 1 (FMR1) gene. FXTAS is often underdiagnosed due to its overlap with other movement disorders such as Parkinson's disease, particularly in patients with no known family history of Fragile X-related conditions.

N/A

CASE REPORT

A 77-year-old man with a ten-year history of progressive gait impairment, balance issues, and recurrent falls presented with a subtle decline in memory over the past year. Despite multiple evaluations, a definitive diagnosis remained elusive. The patient’s family history revealed Fragile X premutation in two nieces, which was not initially considered relevant and was not reported by the patient. Neurological examination showed mild nystagmus, left-predominant bradykinesia, rigidity, titubation, and mild bilateral kinetic tremors. An MRI of the brain revealed generalized atrophy with chronic microvascular ischemic changes, and a DaT scan was abnormal. Genetic testing confirmed a full mutation (>200 repeats) with no methylation of the FMR1 gene, manifesting as a premutation and leading to a diagnosis of FXTAS.

This case underscores the importance of considering FXTAS in the differential diagnosis of late-onset neurodegenerative disorders presenting with tremor, ataxia, and parkinsonism, especially when there is a family history suggestive of Fragile X-related conditions. DaT scan may be abnormal in FXTAS, which can lead to initial misdiagnosis of Parkinson’s disease or Multiple System Atrophy. Early recognition and diagnosis are essential for appropriate management and counselling.

Authors/Disclosures
Aiswarya Raj, MBBS (Westchester Medical Center)
PRESENTER
Dr. Raj has nothing to disclose.
Yana Gordeyeva, MD Ms. Gordeyeva has nothing to disclose.
Elizaveta Abramova, MBBS Dr. Abramova has nothing to disclose.
Malissa Descalzo, MD Dr. Descalzo has nothing to disclose.
Sagari R. Bette, MD (Parkinson's Disease and Movement Disorders Center of Boca Raton) Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Bette has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Bette has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. Dr. Bette has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus.